Clinical Trials Browser

Phase 1/2 × INDUSTRY × roniciclib × Clear all

NCT01573338 2021-04-08

Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 When Given Together With Chemotherapy and the Effectiveness of This Combination Treatment in Shrinking a Specific Type of Lung Tumors (Small Cell Lung Cancer)

Phase 1/2 Terminated

Small Cell Lung Carcinoma